RESUMEN
Peripheral blood stem cell transplantation (PBSCT) requires a high-flow catheter for adequate cell collection by apheresis and long i.v. support, this is usually achieved by multiple catheters. We analyzed our experience with Mahurkar or Permacath for apheresis and long-term i.v. support in PBSCT, cared for exclusively by an i.v. therapy team. Fifty-six catheters were used in 53 patients that completed PBSCT (28 Permacath and 28 Mahurkar). In 10 patients (19%) the same catheter was used for multiple PBSCT. The average stay was 58.4 days (7-219), Permacath 76.8 days (14-219) and Mahurkar 42 days (7-106). The incidence of infectious complications was 2.2 x 1000 catheter-days (1.7 Permacath and 3.0 Mahurkar); during neutropenia it was 3.7 x 1000 cathether-days. The incidence of thrombosis was 0.9 x 1000 catheter-days. There was a total of seven infectious episodes (12.7%). Five (9%) were local and two were (3.6%) bacteremias. The microorganism most commonly isolated was Staphylococcus sp. (57%). Four catheters (7.1%) were removed because of complications: one thrombosis and three infections. Both catheters have proven useful and safe for long-lasting vascular access in patients undergoing PBSCT. No statistical difference was found in infectious and non-infectious complications between either catheters.
Asunto(s)
Cateterismo Periférico/instrumentación , Trasplante de Células Madre Hematopoyéticas , Protocolos de Quimioterapia Combinada Antineoplásica/administración & dosificación , Eliminación de Componentes Sanguíneos/instrumentación , Cateterismo Periférico/efectos adversos , Femenino , Agencias Gubernamentales , Humanos , Masculino , México , Neoplasias/terapiaAsunto(s)
Fraude , Personal de Enfermería en Hospital , Abuso de Sustancias por Vía Intravenosa , Adulto , Femenino , HumanosRESUMEN
DNA vaccines are a promising method of immunization against biothreats and emerging infections because they are relatively easy to design, manufacture, store and distribute. However, immunization with DNA vaccines using conventional delivery methods often fails to induce consistent, robust immune responses, especially in species larger than the mouse. Intramuscular (i.m.) delivery of a plasmid encoding anthrax toxin protective antigen (PA) using electroporation (EP), a potent DNA delivery method, rapidly induced anti-PA IgG and toxin neutralizing antibodies within 2 weeks following a single immunization in multiple experimental species. The delivery procedure is particularly dose efficient and thus favorable for achieving target levels of response following vaccine administration in humans. These results suggest that EP may be a valuable platform technology for the delivery of DNA vaccines against anthrax and other biothreat agents.
Asunto(s)
Vacunas contra el Carbunco , Carbunco/inmunología , Antígenos Bacterianos/inmunología , Bacillus anthracis/inmunología , Toxinas Bacterianas/inmunología , Electroporación , Vacunas de ADN , Adyuvantes Inmunológicos , Animales , Carbunco/prevención & control , Vacunas contra el Carbunco/administración & dosificación , Vacunas contra el Carbunco/genética , Vacunas contra el Carbunco/inmunología , Anticuerpos Antibacterianos/sangre , Antígenos Bacterianos/genética , Toxinas Bacterianas/genética , Bioterrorismo/prevención & control , Femenino , Humanos , Inmunización , Ratones , Pruebas de Neutralización , Plásmidos/genética , Conejos , Ratas , Ratas Sprague-Dawley , Vacunas de ADN/administración & dosificación , Vacunas de ADN/genética , Vacunas de ADN/inmunologíaRESUMEN
Neuroleptic malignant syndrome (NMS) is an adverse reaction of an idiosyncratic nature to drugs having antidopaminergic activity. Pathogenesis is largely disputed. An NMS case is presented which was triggered by flupentixol and was associated with severe hyponatremia (116 mmol/l upon admission). Both clinically and analytically, the hyponatraemia fulfills criteria to be considered secondary to an inappropriate secretion of antidiuretic hormone (SIADH). Other possible causes of hyponatraemia were ruled out. After early treatment with dopaminergic agonists and water restriction, both conditions improved in parallel. The different pathogenetic possibilities which may explain the temporal coexistence of both syndromes in the same patient are discussed. The association of these two conditions is in favour of a probable central pathogenetic cause for NMS. On the other hand, it is suggested that hyponatraemia may mask the diagnosis of NMS.
Asunto(s)
Flupentixol/efectos adversos , Hiponatremia/etiología , Síndrome de Secreción Inadecuada de ADH/complicaciones , Síndrome Neuroléptico Maligno/complicaciones , Trastornos de Adaptación/tratamiento farmacológico , Anciano , Dopaminérgicos/uso terapéutico , Femenino , Humanos , Hiponatremia/diagnóstico , Síndrome de Secreción Inadecuada de ADH/diagnóstico , Síndrome de Secreción Inadecuada de ADH/tratamiento farmacológico , Modelos Biológicos , Síndrome Neuroléptico Maligno/diagnóstico , Síndrome Neuroléptico Maligno/tratamiento farmacológicoRESUMEN
Four newborn patients with symptomatic Chiari II malformations were studied retrospectively. Clinical manifestations and surgical results are presented. All of these patients had hydrocephalus, which was symptomatic in two patients from the first day of life. Three of them had bradycardia and apnea spells. Two patients had lower cranial nerve palsies. Cranial sonography was the first neuroimaging procedure used and it played an important role during the follow-up period, especially for the study of the hydrocephalus. Two newborns could be studied with Magnetic Resonance Imaging (MRI). It defined the level of the decent of the fossa posterior structures and the associated malformations. All of the patients were treated with surgical repair of the spinal dysraphism, ventricular shunt and decompressive surgery. Two patients died before the age of three months. Two other patients showed better evolution after their two year and four year check-ups, respectively. Bradycardia and apnea spells are features that worsen the prognosis as compared with other manifestations.
Asunto(s)
Sistema Nervioso Central/anomalías , Meningomielocele/diagnóstico , Sistema Nervioso Central/cirugía , Femenino , Humanos , Hidrocefalia/diagnóstico , Hidrocefalia/epidemiología , Hidrocefalia/cirugía , Recién Nacido , Masculino , Meningomielocele/epidemiología , Meningomielocele/cirugía , Pronóstico , Estudios Retrospectivos , SíndromeRESUMEN
Reports on supratentorial metastases of medulloblastoma are infrequent. Computed tomography has increased the possibilities of detecting then in a silent clinical phase. Five children with supratentorial metastasis of medulloblastoma were retrospectively reviewed. Diagnosis was established by cranial CT between three and sixty months following treatment of the tumor. Dissemination through the ventricular system was found in all the cases. Other lesions were found in the transition zone between the white and grey matter (2/5) and the left frontal lobe (1/5). The routes of dissemination are discussed. Early diagnosis of supratentorial metastasis of medulloblastoma require periodic cranial CT or magnetic resonance imaging (MRI), at least during the first years after diagnosis and treatment of the primary tumor.
Asunto(s)
Meduloblastoma/patología , Neoplasias Supratentoriales/secundario , Ventrículos Cerebrales/patología , Ventriculografía Cerebral , Niño , Femenino , Humanos , Masculino , Meduloblastoma/diagnóstico , Meduloblastoma/terapia , Metástasis de la Neoplasia , Recurrencia Local de Neoplasia , Radioterapia , Estudios Retrospectivos , Neoplasias Supratentoriales/diagnóstico , Neoplasias Supratentoriales/terapia , Tomografía Computarizada por Rayos XRESUMEN
Means of vascular access are fundamental in the management of cancer. However, since current intravenous devices for long-term treatment are expensive and necessitate a high degree of education among medical personnel, in developing countries they are impractical for use in most of the population. We describe the use of a nontunneled, low-cost, long-lasting Silastic catheter (LLSC), cared for by an intravenous therapy team (IVTT), in 462 patients with cancer. The rate of infectious complications was 0.66 infections per 1,000 catheter-days, which is as low as that reported in association with other catheters in developed countries. Neutropenia and skin and/or soft-tissue infections were significant risk factors associated with LLSC-related infections. We believe that use of this catheter may be an alternative for patients with cancer who need chemotherapy, as long as an IVTT is established for its care. Our experience could be useful for practitioners in countries with similar socioeconomic characteristics.